SSSTAYMHLK* – SIL Dinutuximab signature peptide quantifier

SSSTAYMHLK Stable Isotope Labeled Dinutuximab (DNX) peptide serves as an internal standard to confirm DNX’s primary sequence by mass spectrometry. This allows expected sequences to be confirmed and terminal amino acid homogeneity to be assessed.

SB-PEPTIDE’s Dinutuximab SIL signature peptide quantifier is designed and optimized to provide the best mass spectrometry performance during your Mass Spec assay. For a better detection and quantification, you can use Dinutuximab SIL peptide qualifier, that will induce a complementary signal, with a lower signal-to-noise ratio, for DNX presence confirmation.

Technical specification

Price